Artax Biopharma, Inc. — Form D

Artax Biopharma, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-12. The offering totals $3.5M, of which $750K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Javier GarciaDirectorCambridge, MA
Damia Tormo, Ph.D., MBMDirectorCambridge, MA
Damia Tormo, Ph.D., MBMExecutive OfficerCambridge, MA
Damia W Tormo, Ph.D.DirectorCambridge, MA
Alan W WaltsDirectorCambridge, MA
Raj W ParekhDirectorCambridge, MA
Robert W Armstrong, Ph.D.DirectorCambridge, MA
Robert W Armstrong, Ph.D.Executive OfficerCambridge, MA
Joe W SuarezExecutive OfficerCambridge, MA
Andre W HoekemaDirectorCambridge, MA
Maria W NicholExecutive OfficerCambridge, MA
Casper W BreumDirectorCambridge, MA
Gino W SantiniDirectorCambridge, MA
Gino SantiniDirectorCambridge, MA
Gino SantiniRelated PersonCambridge, MA
Robert ArmstrongDirectorCambridge, MA
Robert ArmstrongExecutive OfficerCambridge, MA
Damia TormoDirectorCambridge, MA
Damia TormoExecutive OfficerCambridge, MA
Casper BreumDirectorNESS ZIONA, L3
Casper BreumRelated PersonNESS ZIONA, L3
Alan WaltsDirectorCambridge, MA
Alan WaltsRelated PersonCambridge, MA
Andre HoekemaDirectorCambridge, MA
Andre HoekemaRelated PersonCambridge, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2026-05-05D/A$19.0M$19.0M
2025-07-29D/A$11.0M$11.0M
2024-08-09D$8.0M$6.0M
2022-05-18D/A$25.8M$25.8M
2022-01-03D$23.2M$12.7M
2021-02-26D$3.0M$2.2M
2020-05-04D$2.0M$2.0M
2015-10-27D$10.0M$3.0M
2014-11-10D$2.0M$2.0M
2013-09-25D$2.0M$1.3M

More